UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Scientific reports, ISSN 2045-2322, 07/2020, Volume 10, Issue 1, pp. 10704 - 10704
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Prognosis | Humans | Cell Survival - genetics | Male | Gene Expression Profiling | Prostatic Neoplasms, Castration-Resistant - genetics | Prostatic Neoplasms, Castration-Resistant - pathology | Prostate - pathology | Cell Line, Tumor | Prostatectomy | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Prostatic Neoplasms, Castration-Resistant - mortality | Cell survival | Castration | Risk assessment | Biomarkers | miRNA | Tumor cell lines | Prostate cancer | Metastases | Index Medicus
Journal Article
EJNMMI research, ISSN 2191-219X, 12/2016, Volume 6, Issue 1, pp. 1 - 7
Medicine & Public Health | Imaging biomarker | Orthopedics | Bone Scan Index (BSI) | Oncology | Nuclear Medicine | Enzalutamide | Imaging / Radiology | Cardiology | Metastatic castration-resistant prostate cancer (mCRPC) | Bone scan | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Urologi och njurmedicin | Cancer and Oncology | Urology and Nephrology | Cancer och onkologi | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
3.
Full Text
DEFECTIVE ENDOSPERM-D1 (Dee-D1) is crucial for endosperm development in hexaploid wheat
Communications biology, 12/2020, Volume 3, Issue 1, pp. 791 - 791
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 10/2017, Volume 84, pp. 18 - 26
Lethal prostate cancer | Prostatic neoplasms | Prognosis | Clinical characteristics | Registries | Danish Prostate Cancer Registry | Cause of death | Epidemiology | Risk factors | Life Sciences & Biomedicine | Oncology | Science & Technology | Predictive Value of Tests | Early Detection of Cancer - methods | Humans | Male | Prostatic Neoplasms - diagnosis | Cause of Death | Incidence | Prostatic Neoplasms - therapy | Neoplasm Grading | Time Factors | Aged, 80 and over | Kallikreins - blood | Retrospective Studies | Databases, Factual | Risk Assessment | Neoplasm Invasiveness | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Lymphatic Metastasis | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Denmark - epidemiology | Aged | Neoplasm Staging | Prostate cancer | Diagnosis | Metastasis | Mortality | Prostate-specific antigen | Population studies | Survival | Lymph nodes | Metastases | Lead time | Medical prognosis | Men | Fatalities | Diagnostic systems | Trends | Prostate | Cancer | Index Medicus
Journal Article
Theoretical and applied genetics, ISSN 0040-5752, 09/2020, Volume 133, Issue 9, pp. 2655 - 2671
Journal Article
The Lancet (British edition), ISSN 0140-6736, 10/2020, Volume 396, Issue 10260, pp. 1413 - 1421
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Radiotherapy | Surgery | Analysis | Radicals | Schedules | Prostate-specific antigen | Clinical trials | Stenosis | Oncology | Biochemistry | Metastasis | Pelvis | Cancer therapies | Risk factors | Metastases | Randomization | Safety | Antigens | Medical research | Endocrine therapy | Radiation therapy | Risk analysis | Survival | Patients | Morbidity | Meta-analysis | Urinary incontinence | Prostate cancer | Prostate | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
BMJ open, ISSN 2044-6055, 12/2020, Volume 10, Issue 12, pp. e040965 - e040965
Journal Article
Surgical oncology, ISSN 0960-7404, 2016, Volume 26, Issue 1, pp. 21 - 27
Hematology, Oncology and Palliative Medicine | Surgery | Radical prostatectomy | Prostate cancer | Survival | Competing risk | Mortality | Oncology | Life Sciences & Biomedicine | Science & Technology | Prostatic Neoplasms - pathology | Prognosis | Follow-Up Studies | Prostatic Neoplasms - surgery | Humans | Middle Aged | Male | Survival Rate | Prostatic Neoplasms - mortality | Neoplasm Grading | Time Factors | Denmark | Aged | Prostatectomy - mortality | Neoplasm Staging | Cohort Studies | Analysis | Health aspects | Survival analysis | Pneumonia | Lung diseases | Leukemia | Classification | Emigration | Firearms | Multivariate analysis | Patients | Index Medicus
Journal Article
International journal of molecular sciences, ISSN 1661-6596, 03/2019, Volume 20, Issue 5, p. 1025
5hmC | ERG | Radical prostatectomy | Prostate cancer | Predictive biomarkers | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Multivariate Analysis | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - surgery | 5-Methylcytosine - analogs & derivatives | Humans | Middle Aged | Proportional Hazards Models | Transcriptional Regulator ERG - metabolism | Male | 5-Methylcytosine - metabolism | Prostatectomy | ROC Curve | Aged | Cohort Studies | Studies | ERG protein | Prediction models | DNA methylation | Biomarkers | Immunoreactivity | Prostate | Tumors | Cancer | Nomographs | predictive biomarkers | prostate cancer | radical prostatectomy
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 08/2019, Volume 157, Issue 2, pp. 569 - 571
Journal Article
Scandinavian journal of urology, ISSN 2168-1805, 06/2014, Volume 48, Issue 3, pp. 268 - 275
abiraterone | castration-resistant prostate cancer | post-chemotherapy | enzalutamide | sequencing | Castration-resistant prostate cancer | Post-chemotherapy | Enzalutamide | Abiraterone | Sequencing | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Phenylthiohydantoin - therapeutic use | Compassionate Use Trials | Humans | Middle Aged | Linear Models | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Prostatic Neoplasms, Castration-Resistant - drug therapy | Abiraterone Acetate | Phenylthiohydantoin - analogs & derivatives | Disease-Free Survival | Taxoids - therapeutic use | Treatment Failure | Aged | Androstadienes - therapeutic use | Prostate-Specific Antigen - metabolism | Kallikreins - metabolism | Cohort Studies | Index Medicus
Journal Article
Urologic oncology, ISSN 1078-1439, 2016, Volume 34, Issue 7, pp. 291.e1 - 291.e7
Urology | Efficacy | Metastatic castration-resistant prostate cancer | Routine practice | Abiraterone acetate | Oncology | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Humans | Middle Aged | Androstenes - therapeutic use | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Prostatic Neoplasms, Castration-Resistant - drug therapy | Prostatic Neoplasms, Castration-Resistant - pathology | Neoplasm Metastasis - drug therapy | Aged, 80 and over | Androgen Antagonists - therapeutic use | Aged | Retrospective Studies | Care and treatment | Chemotherapy | Metastasis | Prostate cancer | Cytochrome P-450 | Cancer | Index Medicus
Journal Article